News about "USA Import Tariff Risk Amid Latest Policy Shift Ph"

Asian and European Drugmakers' Branded Medications Face USA Import Tariff Risk Amid Latest Policy Shift

Asian and European Drugmakers' Branded Medications Face USA Import Tariff Risk Amid Latest Policy Shift

In recent statements, the USA government announced plans to impose a 100 per cent tariff on branded pharmaceutical products from firms that have not established USA-based manufacturing, unless construction of such facilities has already begun.

USA Import Tariff Risk Amid Latest Policy Shift Ph | 29/09/2025 | By Darshana


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members